Elisabet Berastegui

Elisabet Berastegui (Patient Care > Cardiac Surgery > About us) | iCor | Institut del Cor del germans Trias i Pujol

Eli Berastegui

Cardiac surgeon


Cardiac surgery

Academic training

• 1999-2005 Degree in Medicine, University of Barcelona.
• 2009-2011 Pre-Doctorate Universidad Autònoma de Barcelona, Department of Surgery and Surgical Specialties: Thesis - Research Sufficiency. (M.d. H). Tetralogy of Fallot "Remodeling of the right ventricle after pulmonary valve replacement".
• November 2017 BOARD European Cardiothoracic Surgery Certification.
• February 2018 DOCTOR IN MEDICINE. Universidad Autònoma de Barcelona. Thesis entitled "Predictors of morbidity and mortality in the over 70 years undergoing a procedure on the aortic valve Excel.lent Cum Laude.

Research stays / fellowship / Professional career

• Resident Physician of Cardiovascular Surgery at the Vall d'Hebron University Hospital, a place obtained by the National Merit Contest in 2006, completing the training according to the current Resident Physician Training Plan.
• Medical Specialist in Cardiovascular Surgery. Assistance work in Hospital de Germans Trias i Pujol in Badalona. 2011 to 2013.
• Medical Specialist in Cardiovascular Surgery. Assistance work in Hospital de Germans Trias i Pujol in Badalona. 2013 to 2018 as interin position.
• Medical Specialist in Cardiovascular Surgery. Functionary. Metropolitan Nord area. July 2018.

Areas of interest

• Aortic valve pathology.
• Pathology of the Aorta.
• Heart failure.
• Ecmo and ventricular device.
• Risk scales.


• Prótesis sin sutura Perceval S (Livanova, Saluggia, Italia)en la cirugía valvular aórtica de alto riesgo. Una herramienta fundamental para el cirujano Rev.Española Ci. Cardiovascular. 2017.
• Sustitución valvular aórtica por bioprótesis sin sutura en pacientes de alto riesgo: Registro Pavarotti Pavarotti registry: Perceval aortic valve alternative in high risk aortic patients. Rev.Fed. Argentina. 2015.
• How to develop a simply frailty score for predicting postoperative morbidity in cardiac surgery. Cardiology Open Acces. 2017.
• Intermediate Care Unit After Cardiac Surgery: Impact on Length of Stay and Outcomes. Rev.Española Cardiologia. 2017.
• Incidence and predictors of new-onset atrioventricular block requiring pacemaker implantation after sutureless aortic valve replacement.Interactive Cardiovascularand Thoracic Surgery. 2016.
• Perceval Less Invasive Aortic Replacement Register: multicéntrica Spanish experience with the Perceval S bioprosthesis in moderate–high-risk aortic surgery. Interactive Cardiovascular and Thoracic Surgery. 2018.
• Masa en aurícula izquierda, síndrome antifosfolípido inducido por linfoma. Cir Cardiov 2018;25:153-4.
• Revascularización miocárdica con uso de doble arteria mamaria interna y morbilidad esternal. Experiencia de un centro. Cir Cardiov 2017;24:149-56.
• Reparación valvular de la insuficiencia mitral degenerativa.Evolución clínica y ecocardiográfica según el grado de regurgitación residual intraoperatoria. Cir Cardiov 2013;20:25-30.
• Thromboembolism and bleeding in patients with cancer and mechanical heart valves. Journal of Thrombosis and Thrombolysis.